2cureX AB (publ)

OM:2CUREX Rapporto sulle azioni

Cap. di mercato: SEK 7.9m

2cureX Gestione

Gestione criteri di controllo 2/4

2cureX's CEO is Ole Thastrup, appointed in Jan 2006, has a tenure of 18.83 years. total yearly compensation is SEK300.00K, comprised of 50% salary and 50% bonuses, including company stock and options. directly owns 23.8% of the company’s shares, worth SEK1.87M. The average tenure of the management team and the board of directors is 3.8 years and 2 years respectively.

Informazioni chiave

Ole Thastrup

Amministratore delegato

SEK 300.0k

Compenso totale

Percentuale dello stipendio del CEO50.0%
Mandato del CEO18.8yrs
Proprietà del CEO23.8%
Durata media del management3.8yrs
Durata media del Consiglio di amministrazione2yrs

Aggiornamenti recenti sulla gestione

Recent updates

We're Not Very Worried About 2cureX's (STO:2CUREX) Cash Burn Rate

Jun 03
We're Not Very Worried About 2cureX's (STO:2CUREX) Cash Burn Rate

2cureX (STO:2CUREX) Is In A Good Position To Deliver On Growth Plans

Jan 06
2cureX (STO:2CUREX) Is In A Good Position To Deliver On Growth Plans

We're Not Very Worried About 2cureX's (STO:2CUREX) Cash Burn Rate

Sep 23
We're Not Very Worried About 2cureX's (STO:2CUREX) Cash Burn Rate

We're Interested To See How 2cureX (STO:2CUREX) Uses Its Cash Hoard To Grow

Jun 02
We're Interested To See How 2cureX (STO:2CUREX) Uses Its Cash Hoard To Grow

Shareholders Of 2cureX (STO:2CUREX) Must Be Happy With Their 280% Total Return

Feb 18
Shareholders Of 2cureX (STO:2CUREX) Must Be Happy With Their 280% Total Return

How Does 2cureX's (STO:2CUREX) CEO Salary Compare to Peers?

Nov 29
How Does 2cureX's (STO:2CUREX) CEO Salary Compare to Peers?

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Ole Thastrup rispetto agli utili di 2cureX?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

-SEK 26m

Mar 31 2024n/an/a

-SEK 30m

Dec 31 2023SEK 300kSEK 150k

-SEK 33m

Sep 30 2023n/an/a

-SEK 33m

Jun 30 2023n/an/a

-SEK 31m

Mar 31 2023n/an/a

-SEK 29m

Dec 31 2022SEK 150kn/a

-SEK 30m

Sep 30 2022n/an/a

-SEK 29m

Jun 30 2022n/an/a

-SEK 26m

Mar 31 2022n/an/a

-SEK 25m

Dec 31 2021SEK 150kn/a

-SEK 19m

Sep 30 2021n/an/a

-SEK 15m

Jun 30 2021n/an/a

-SEK 10m

Mar 31 2021n/an/a

-SEK 8m

Dec 31 2020SEK 2mSEK 2m

-SEK 7m

Sep 30 2020n/an/a

-SEK 7m

Jun 30 2020n/an/a

-SEK 8m

Mar 31 2020n/an/a

-SEK 8m

Dec 31 2019SEK 2mSEK 2m

-SEK 8m

Sep 30 2019n/an/a

-SEK 6m

Jun 30 2019n/an/a

-SEK 6m

Mar 31 2019n/an/a

-SEK 6m

Dec 31 2018SEK 2mSEK 2m

-SEK 7m

Compensazione vs Mercato: Ole's total compensation ($USD28.14K) is below average for companies of similar size in the Swedish market ($USD242.77K).

Compensazione vs guadagni: Ole's compensation has increased whilst the company is unprofitable.


AMMINISTRATORE DELEGATO

Ole Thastrup (71 yo)

18.8yrs

Mandato

SEK 300,000

Compensazione

Mr. Ole Thastrup is CEO of 2cureX AB (publ) since June 2024 and serves as it's Vice Chairman of the Board since January 01, 2024 and served as the Chief Scientific Officer since January 2021 until January...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Ole Thastrup
Co-Founder18.8yrsSEK 300.00k23.8%
SEK 1.9m
Grith Hagel
Co-Founderno dataNessun dato3.87%
SEK 304.0k
Kenneth Johansen
Chief Financial Officer3.8yrsNessun dato0.023%
SEK 1.8k
Jacob Thastrup
Chief Technology Officerless than a yearNessun dato0.062%
SEK 4.9k
Manuel Fernandez
Director Quality & Regulatory Affairsno dataNessun datoNessun dato

3.8yrs

Durata media

56.5yo

Età media

Gestione esperta: 2CUREX's management team is considered experienced (3.8 years average tenure).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Ole Thastrup
Co-Founder18.8yrsSEK 300.00k23.8%
SEK 1.9m
Grith Hagel
Co-Founderless than a yearNessun dato3.87%
SEK 304.0k
John Marshall
Member of Clinical Advisory Board3.3yrsNessun datoNessun dato
Tonni Bülow-Nielsen
Chairman of the Boardless than a yearNessun datoNessun dato
Jesus Garcia-Foncillas
Member of Clinical Advisory Board3.3yrsNessun datoNessun dato
Andrew Beggs
Member of Clinical Advisory Board3yrsNessun datoNessun dato
Nathaniel Hutley
Directorless than a yearNessun datoNessun dato
Dan Honeywell
Directorless than a yearNessun datoNessun dato

2.0yrs

Durata media

Consiglio di amministrazione esperto: 2CUREX's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.